Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1625-1633

  Conrady, Christopher D ^a   Halford, William P ^b   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; MEDROXYPROGESTERONE; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; FEMALE; GENITAL HERPES SIMPLEX VIRUS 2 INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SPINAL CORD; VIRUS VIRULENCE;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; INTERFERON TYPE I; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; SPINAL CORD; T-LYMPHOCYTES, CYTOTOXIC; VAGINA; VIRUS REPLICATION;

HERPES; HUMAN HERPESVIRUS 2; MUS; SIMPLEXVIRUS;

EID: 78951477739     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01715-10     Document Type: Article

References (66)

1. Abu-Raddad, L. J., et al. 2008. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 3:e2230.
2. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5:266-271.
3. Antonelli, L.R., et al. 2010. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120:1674-1682.
4. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10168-10171.
5. Ashkar, A. A., et al. 2004. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190:1841-1849.
6. Austin, B. A., C. M. James, P. Härle, and D. J. J. Carr. 2006. Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biol. Proced. Online 8:55-62.
7. Baker, D. A., and S. A. Plotkin. 1978. Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone (40156). Proc. Soc Exp. Biol. Med. 158:131-134.
8. Bird, M. D., C.-F. Chu, A. J. Johnson, and G. N. Milligan. 2007. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J. Virol. 81:423-426.
9. Caligioni, C. S. 2009. Unit 4I. Assessing reproductive status/stages in mice. Curr. Protoc. Neurosci. doi:10.1002/0471142301.nsa04is48.
10. Carr, D. J. J., L. Tomanek, R. H. Silverman, I. L. Campbell, and B. R. G. Williams. 2005. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J. Virol. 79:9341-9345.
11. Conrady, C. D., M. Thapa, T. Wuest, and D. J. J. Carr. 2009. Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice. J. Immunol. 182:3678-3687.
12. Conti, P., and M. DiGioacchino. 2001. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 22:133-137.
13. + T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J. Virol. 79:14546-14554.
14. Dudley, K. L., N. Bourne, and G. N. Milligan. 2000. Immune protection against HSV-2 in B-cell-deficient mice. Virology 270:454-463.
15. Fabricius, D., et al. 2010. Prostaglandin E2 inhibits IFN-α secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J. Immunol. 184:677-684.
16. + T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 180:1556-1564.
17. Fernandez, S., A. Gillgrass, and C. Kaushik. 2007. Differential response of murine vaginal and uterine epithelial cells prior to and following herpes simplex virus type 2 (HSV-2) infection. Am. J. Reprod. Immunol. 57:367-377.
18. Freeman, E. E., et al. 2006. Herpes simplex virus type 2 infection increases HIV acquisition in men and women: systemic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
19. Garvey, T. L., et al. 2005. Inflammatory responses to pneumovirus infection in IFN-α/β R gene-deleted mice. J. Immunol. 175:4735-4744.
20. Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptorrelated protein 1 and poliovirus receptor. Science 280:1618-1620.
21. Harandi, A. M., K. Eriksson, and J. Holmgren. 2003. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77:953-962.
22. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82:845-853.
23. Harandi, A. M., B. Svennerholm, J. Holmgren, and K. Eriksson. 2001. Protective vaccination against genital herpes simplex virus type (HSV-2) infection in mice is associated with a rapid induction of local IFN-gammadependent RANTES production following a vaginal viral challenge. Am. J. Reprod. Immunol. 46:420-424.
24. Härle, P., et al. 2002. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76:6558-6567. (Pubitemid 34633521)
25. Härle, P., et al. 2002. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res. 56:39-49. (Pubitemid 35248107)
26. Härle, P., S. Noisakran, and D. J. J. Carr. 2001. The application of a plasmid DNA encoding IFN-α1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J. Immunol. 166:1803-1812.
27. Iijima, N., et al. 2008. Dendritic cells and B cells maximize mucosal memory responses to herpes simplex virus. J. Exp. Med. 205:3041-3052.
28. Iijima, N., J. M. Thompson, and A. Iwasaki. 2008. Dendritic cells and macrophages in the genitourinary tract. Mucosal Immunol. 1:451-459.
29. Kaushic, C., A. A. Ashkar, L. A. Reid, and K. L. Rosenthal. 2003. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 77:4558-4565.
30. Koelle, D. M., et al. 2001. CD8 CTL from genital herpes simplex virus lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166:4049-4058.
31. Lee, S. K., et al. 2008. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol. Cells 26:67-73.
32. Linehan, M. M., et al. 2004. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J. Virol. 78:2530-2536.
33. Looker, K. J., G. P. Garnett, and G. P. Schmid. 2008. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 86:805-812.
34. Lund, J., A. Sato, S. Akira, R. Mudzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
35. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220-1224.
36. McFarland, W., et al. 1999. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J. Infect. Dis. 180:459-465.
37. Mertz, G. J., J. Benedetti, R. Ashley, S. A. Selke, and L. Corey. 1992. Risk factors for sexual transmission of genital herpes. Ann. Intern. Med. 116:197-202.
38. Milligan, G. N. 1999. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73:6380-6386. (Pubitemid 29327815)
39. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:159-268.
40. Milligan, G. N., K. L. Dudley-McClain, C. G. Young, and C.-F. Chu. 2004. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice. J. Reprod. Immunol. 61:115-127.
41. Miyaura, H., and M. Iwat. 2002. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168:1087-1094.
42. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87:427-436.
43. Nakajima, H., M. Kobayashi, R. B. Pollard, and F. Suzuki. 2001. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J. Leukoc. Biol. 70:374-380.
44. + T-cell help. Nature 462:510-514.
45. Parr, M. B., et al. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:369-380.
46. Parr, M. B., and E. L. Parr. 1998. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:2677-2685.
47. Parr, M. B., and E. L. Parr. 1999. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258:282-294.
48. Parr, M. B., and E. L. Parr. 2000. Interferon-γ up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunology 99:540-545.
49. Peng, T., et al. 2009. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J. Virol. 83:12559-12568.
50. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165-8168.
51. + cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. U. S. A. 94:10289-10294.
52. Pyles, R. B., et al. 2002. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J. Virol. 76:11387-11396.
53. Schillinger, J. A., et al. 2008. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex. Transm. Dis. 35:599-606.
54. + T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J. Virol. 74:11173-11180.
55. Svensson, A., L. Bellner, M. Magnusson, and K. Eriksson. 2007. Role of IFN-α/β signaling in the prevention of genital herpes virus type 2 infection. J. Reprod. Immunol. 74:114-123.
56. Svensson, A., I. Nordström, J.-B. Sun, and K. Eriksson. 2005. Protective immunity to genital herpes simplex virus type 2 infection is mediated by T-bet. J. Immunol. 174:6266-6273.
57. Thapa, M., and D. J. J. Carr. 2008. Chemokines and chemokine receptors critical to host resistance following genital herpes simplex virus type 2 (HSV-2) infection. Open Immunol. J. 1:33-41.
58. + T-cell effector function but not migration. J. Virol. 83:9486-9501.
59. Thapa, M., W. A. Kuziel, and D. J. J. Carr. 2007. Susceptibility of CCR5- deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81:3704-3713.
60. Thapa, M., R. S. Welner, R. Pelayo, and D. J. J. Carr. 2008. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J. Immunol. 180:1098-1106.
61. Wald, A., J. Zeh, S. Selke, T. Warren, A. J. Ryncarz, R. Ashley, J. N. Krieger, and L. Corey. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342:844-850.
62. Warner, M. S., et al. 1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246:179-189.
63. Xu, F., et al. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalance in the United States. JAMA 296:964-973.
64. Zhao, X., et al. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:153-162.
65. Zhu, J., et al. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15:886-892.
66. + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204:595-603.